These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34612079)

  • 41. Comparison of International Systemic Adverse Reactions Due to Allergen Immunotherapy.
    Vidal C; Rodríguez Del Río P; Gude F; Casale T; Cox L; Just J; Pfaar O; Demoly P; Calderón MA
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1298-1305.e3. PubMed ID: 30557714
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Food-induced anaphylaxis and repeated epinephrine treatments.
    Oren E; Banerji A; Clark S; Camargo CA
    Ann Allergy Asthma Immunol; 2007 Nov; 99(5):429-32. PubMed ID: 18051213
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of epinephrine and diphenhydramine rinses in decreasing local reactions to subcutaneous aeroallergen immunotherapy.
    Mustafa SS; Vadamalai K; Bingemann T; Ramsey A
    Allergy Asthma Proc; 2020 Jan; 41(1):52-58. PubMed ID: 31888783
    [No Abstract]   [Full Text] [Related]  

  • 44. Allergen immunotherapy: an updated review of safety.
    James C; Bernstein DI
    Curr Opin Allergy Clin Immunol; 2017 Feb; 17(1):55-59. PubMed ID: 27906697
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Safety considerations in providing allergen immunotherapy in the office.
    Mattos JL; Lee S
    Curr Opin Otolaryngol Head Neck Surg; 2016 Jun; 24(3):226-30. PubMed ID: 27092905
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prehospital Epinephrine Use in Pediatric Anaphylaxis by Emergency Medical Services.
    Lowing D; Chung S; Luk J; Dingeldein L
    Pediatr Emerg Care; 2022 Aug; 38(8):367-371. PubMed ID: 35696300
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anaphylaxis in the allergy practice.
    Leatherman BD
    Int Forum Allergy Rhinol; 2014 Sep; 4 Suppl 2():S60-5. PubMed ID: 25182358
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Improving anaphylaxis management in a pediatric emergency department.
    Arroabarren E; Lasa EM; Olaciregui I; Sarasqueta C; Muñoz JA; Pérez-Yarza EG
    Pediatr Allergy Immunol; 2011 Nov; 22(7):708-14. PubMed ID: 21672025
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Syringe Administration of Epinephrine by Emergency Medical Technicians for Anaphylaxis.
    Latimer AJ; Husain S; Nolan J; Doreswamy V; Rea TD; Sayre MR; Eisenberg MS
    Prehosp Emerg Care; 2018; 22(3):319-325. PubMed ID: 29333893
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prescriptions for self-injectable epinephrine and follow-up referral in emergency department patients presenting with anaphylaxis.
    Campbell RL; Luke A; Weaver AL; St Sauver JL; Bergstralh EJ; Li JT; Manivannan V; Decker WW
    Ann Allergy Asthma Immunol; 2008 Dec; 101(6):631-6. PubMed ID: 19119708
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Allergy and Asthma: Anaphylaxis.
    Vandervoort R
    FP Essent; 2018 Sep; 472():20-24. PubMed ID: 30152670
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Systemic reactions to immunotherapy.
    Matloff SM; Bailit IW; Parks P; Madden N; Greineder DK
    Allergy Proc; 1993; 14(5):347-50. PubMed ID: 8288117
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety of rush immunotherapy using a modified schedule: a cumulative experience of 893 patients receiving multiple aeroallergens.
    Smits WL; Giese JK; Letz KL; Inglefield JT; Schlie AR
    Allergy Asthma Proc; 2007; 28(3):305-12. PubMed ID: 17619559
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Systemic reactions to subcutaneous allergen immunotherapy.
    Bernstein DI; Epstein T
    Immunol Allergy Clin North Am; 2011 May; 31(2):241-9, viii-ix. PubMed ID: 21530817
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Use of epinephrine for anaphylaxis by emergency medical technicians in a wilderness setting.
    Fortenberry JE; Laine J; Shalit M
    Ann Emerg Med; 1995 Jun; 25(6):785-7. PubMed ID: 7755201
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Changes in Emergency Department Concordance with Guidelines for the Management of Food-Induced Anaphylaxis: 1999-2001 versus 2013-2015.
    Clark S; Boggs KM; Balekian DS; Hasegawa K; Vo P; Rowe BH; Camargo CA;
    J Allergy Clin Immunol Pract; 2019; 7(7):2262-2269. PubMed ID: 30974210
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Who needs to carry an epinephrine autoinjector?
    Song TT; Lieberman P
    Cleve Clin J Med; 2019 Jan; 86(1):66-72. PubMed ID: 30624186
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epinephrine for First-aid Management of Anaphylaxis.
    Sicherer SH; Simons FER;
    Pediatrics; 2017 Mar; 139(3):. PubMed ID: 28193791
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Safety of immunotherapy and skin tests with allergens in children younger than five years].
    Rodríguez Pérez N; Ambriz Moreno Mde J
    Rev Alerg Mex; 2006; 53(2):47-51. PubMed ID: 16884027
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adverse effects and fatalities associated with subcutaneous allergen immunotherapy.
    Bukantz SC; Bagg AS; Lockey RF
    Clin Allergy Immunol; 2008; 21():455-68. PubMed ID: 18828523
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.